CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,161,510 | +4.2% | 2,890,775 | +23.9% | 0.01% | +8.3% |
Q2 2023 | $25,114,766 | +211.1% | 2,334,086 | +195.8% | 0.01% | +200.0% |
Q1 2023 | $8,072,880 | -2.2% | 789,138 | +0.9% | 0.00% | 0.0% |
Q4 2022 | $8,251,429 | -18.0% | 782,126 | -0.4% | 0.00% | -20.0% |
Q3 2022 | $10,067,000 | +0.8% | 785,219 | +0.8% | 0.01% | 0.0% |
Q2 2022 | $9,988,000 | +22.6% | 779,082 | +0.2% | 0.01% | +66.7% |
Q1 2022 | $8,144,000 | -31.9% | 777,880 | +0.4% | 0.00% | -25.0% |
Q4 2021 | $11,951,000 | -31.8% | 774,534 | -0.2% | 0.00% | -42.9% |
Q3 2021 | $17,524,000 | -12.5% | 776,406 | -0.1% | 0.01% | -12.5% |
Q2 2021 | $20,021,000 | -1.6% | 777,498 | +59.2% | 0.01% | 0.0% |
Q1 2021 | $20,348,000 | – | 488,308 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |